First Eagle Investment Management LLC Has $18.93 Million Position in Cabot Corporation $CBT

First Eagle Investment Management LLC boosted its holdings in Cabot Corporation (NYSE:CBT) by 52.5% in the second quarter, Holdings Channel reports. The institutional investor owned 208,450 shares of the specialty chemicals company’s stock after buying an additional 71,800 shares during the period. First Eagle Investment Management LLC’s holdings in Cabot were worth $18,931,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. Rothschild Investment LLC grew its holdings in Cabot by 170.4% during the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after acquiring an additional 259 shares during the last quarter. Northwestern Mutual Wealth Management Co. bought a new stake in shares of Cabot in the 2nd quarter valued at about $33,000. Global Retirement Partners LLC grew its position in shares of Cabot by 1,606.9% in the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 466 shares during the last quarter. Geneos Wealth Management Inc. raised its position in shares of Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after acquiring an additional 364 shares during the last quarter. Finally, Danske Bank A S bought a new position in shares of Cabot during the third quarter worth about $38,000. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Sean Keohane sold 134,895 shares of the firm’s stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the completion of the sale, the chief executive officer owned 404,134 shares of the company’s stock, valued at $34,351,390. This trade represents a 25.03% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. In the last quarter, insiders sold 229,597 shares of company stock worth $19,646,746. 3.08% of the stock is currently owned by corporate insiders.

Cabot Stock Performance

CBT stock opened at $81.47 on Monday. The stock has a 50-day moving average price of $86.67 and a 200-day moving average price of $81.44. Cabot Corporation has a 1-year low of $58.33 and a 1-year high of $94.53. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48. The firm has a market cap of $4.21 billion, a PE ratio of 22.95, a price-to-earnings-growth ratio of 10.70 and a beta of 0.83.

Cabot (NYSE:CBT) last announced its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, beating the consensus estimate of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The company had revenue of $982.00 million for the quarter, compared to analyst estimates of $943.16 million. During the same quarter in the prior year, the company earned $1.90 EPS. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, equities research analysts expect that Cabot Corporation will post 6.35 earnings per share for the current year.

Cabot Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be issued a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Friday, August 28th. Cabot’s dividend payout ratio is presently 53.24%.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. JPMorgan Chase & Co. increased their target price on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research report on Friday, August 7th. Mizuho raised their price target on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Thursday, June 25th. Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a research report on Friday, August 21st. Finally, Truist Financial set a $100.00 price objective on shares of Cabot in a research note on Wednesday, August 5th. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $89.00.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.